Children’s services models

Magellan Healthcare sets the benchmark for advancements in behavioral health and child care models. Our behavioral health thought leadership is nationally recognized and we share it with you through the resources on this page.

MarComm Awards Gold Winner

Magellan Healthcare is pleased to be a 2021 MarCom Awards Gold recipient in the category of technical writing for our below monograph, Understanding and Meeting the Needs of Children and Adolescents at High Risk: Foundations of a Model!

MarCom is an international creative competition that recognizes the outstanding achievement of marketing and communications professionals.

Appropriate Use of Psychotropic Drugs in Children and Adolescents: Important Issues and Evidence-Based Treatments

Culminating mental health challenges for young people, made worse by the pandemic, have initiated the Surgeon General and leading children’s health organizations in issuing declarations of a youth mental health crisis.1 Our updated monograph provides an in-depth analysis of an integral issue–the increasing rate of psychotropic drug prescribing in the treatment of young people.

Originally published in 2013, our monograph highlights the evidence-based research on the use of psychotherapeutic agents in children and principles for optimal children’s psychopharmacotherapy practice that underpins our model of care for serving children, youth and their families.

2022 revision

In January 2022, Magellan completed an extensive review and update of the monograph to incorporate the most current research, including on the following, and continue to serve as a resource for primary care physicians, including pediatricians, and behavioral health practitioners in making decisions–as well as families to learn more and be informed–about behavioral health treatment options for children and adolescents. This research and information is also available for advocacy organizations and policymakers in advancing a public policy agenda and best practices to meet the challenges of children, youth and families involved in all child-serving systems.

  • New indications since the last update in 2017
  • Nature and scope of the problem
  • Children in foster care
  • Controversies in clinical management
  • Principles for optimal psychopharmacotherapy practice
  • Efficacy of psychotherapeutic agents in treating mood disorders, obsessive-compulsive disorder, anxiety disorders, post-traumatic stress disorder, disruptive behavioral disorders/aggression, attention-deficit/hyperactivity disorder, developmental disabilities and eating disorders
  • Drug treatment effects on nervous system development

Learn more in the full monograph, summary and at-a-glance drug information documents here:

2022
Appropriate use of psychotropic drugs in children and adolescents: Important issues and evidence-based treatments
  • Full clinical monograph on the use of psychopharmacological treatments and principles for optimal psychopharmacotherapy practice in children and adolescents
2022
Monograph summary: Appropriate use of psychotropic drugs in children and adolescents
  • Summary of full clinical monograph
2022
At-a-glance: Psychotropic drug information for children and adolescents
  • Evidence-based review of psychotropic medications, including dosage ranges, warnings, common side effects, teratogenic risks and recommended monitoring, used to treat specific behavioral health disorders in children and adolescents

Understanding and Meeting the Needs of Children and Adolescents at High Risk: Foundations of a Model

Our comprehensive approach to children’s behavioral health is youth-guided and family-driven to achieve the best outcomes and high member satisfaction. Within complex care delivery systems, we effectively integrate and coordinate care, focusing on the individual needs, strengths, preferences and culture of each child and youth.

Originally published in 2015, our monograph highlights the evidence-based research on the prevention and treatment of problematic behaviors and various types of behavioral health challenges in children and adolescents that underpins our model of care for serving children, youth and their families.

2020 revision 

In December 2020, Magellan completed an extensive review and update of the monograph to incorporate the most current children’s behavioral health research, including the following, and continue to serve as a resource for youth, families, policymakers and advocates, community stakeholders, and providers in understanding the issues and barriers involved in the treatment of children and youth:

  • Children with parents who have mental health and/or substance use disorders
  • Childhood trauma and trauma-informed care
  • Youth drug use trends
  • Youth suicide and impacts from the COVID-19 pandemic
  • Monitoring clinical, social and adaptive outcomes

Learn more in the full monograph and summary documents here:

2020
Understanding and meeting the needs of children and adolescents at high risk: Foundations of a model
  • Full clinical monograph on the prevention and treatment of problematic behaviors and various types of behavioral health challenges in children and adolescents
2021
Monograph summary: Understanding and meeting the needs of children and adolescents at high risk
  • Summary of full clinical monograph

Magellan Healthcare Programs and Services

Explore our customizable behavioral health solutions for government and commercial health plan partners to provide better, more affordable care for adults, children and their families.

Learn more

Put our behavioral health expertise to work for your program

Contact us to learn how we can customize our behavioral health solutions to meet the needs of the individuals you serve.